Ativan* — Medicare Part D Spending

Generic: Lorazepam | Manufacturer: Overall

2023 Spending

$24.3M

2023 Claims

6,575

2023 Beneficiaries

1,309

Cost/Unit (2023)

$43.65

5-Year Spending Trend (2019-2023)

Year	Total Spending	Claims	Beneficiaries	Cost/Unit
2019	$26.2M	9,774	1,719	$33.65
2020	$22.4M	7,112	1,192	$37.32
2021	$23.7M	6,719	1,074	$40.82
2022	$24.3M	6,468	1,099	$43.60
2023	$24.3M	6,575	1,309	$43.65

5Y CAGR (cost/unit): 6.7%YoY Change (2022-2023): 0.1%

📊

DrugPricePeek Editorial TeamData Specialists

The DrugPricePeek editorial team aggregates and verifies drugs data from CMS NADAC & Medicare Part D. Every statistic on this site is cross-referenced against the official source before publication, with quarterly re-verification cycles.

✓ Sourced from CMS NADAC & Medicare Part D✓ Quarterly review✓ No paid placements

Read our full methodology or contact us with corrections.

Frequently Asked Questions

How much does Medicare spend on Ativan*?

In 2023, Medicare Part D spent $24.3M on Ativan* (Lorazepam), serving 1,309 beneficiaries across 6,575 claims.

What is the cost per unit of Ativan* under Medicare?

The weighted average cost per dosage unit of Ativan* was $43.65 in 2023. The 5-year compound annual growth rate (2019-2023) was 6.7%.

Who manufactures Ativan*?

Ativan* (generic name: Lorazepam) is manufactured by Overall. There are 2 manufacturer(s) listed in the CMS database for this drug.

Is Ativan* covered by Medicare Part D?

Yes, Ativan* is included in Medicare Part D spending data, indicating it is covered by Part D plans. However, specific coverage and tier placement vary by plan. Check with your specific Part D plan for formulary details.

Where does this Medicare spending data come from?

All Medicare Part D spending data comes from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Spending by Drug dataset, which is publicly available at data.cms.gov.

Explore the DataPeek Network

MedCheckWize MedCostPeek CareFindPeek BreathePeek VetCostPeek VocabWize VocabLibre DicionarioWize WortWize KalimaWize KotobaPeek NameBlooms WagePeek NetPayPeek SalaryByCity CostByCity

Year

Total Spending

Claims

Beneficiaries

Cost/Unit

2019

$26.2M

9,774

1,719

$33.65

2020

$22.4M

7,112

1,192

$37.32

2021

$23.7M

6,719

1,074

$40.82

2022

$24.3M

6,468

1,099

$43.60

2023

$24.3M

6,575

1,309

$43.65

Frequently Asked Questions

How much does Medicare spend on Ativan*?

In 2023, Medicare Part D spent $24.3M on Ativan* (Lorazepam), serving 1,309 beneficiaries across 6,575 claims.

What is the cost per unit of Ativan* under Medicare?

The weighted average cost per dosage unit of Ativan* was $43.65 in 2023. The 5-year compound annual growth rate (2019-2023) was 6.7%.

Who manufactures Ativan*?

Ativan* (generic name: Lorazepam) is manufactured by Overall. There are 2 manufacturer(s) listed in the CMS database for this drug.

Is Ativan* covered by Medicare Part D?

Where does this Medicare spending data come from?

All Medicare Part D spending data comes from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Spending by Drug dataset, which is publicly available at data.cms.gov.